Immunoprecise Antibodies Ltd (IPA) — Cash Flow Reinvestment Rate
Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Reinvestment Rate of 3.25x as of October 2020, reinvesting $1.43 Million (capex $715.21K plus investments $-715.21K) from operating cash flow of $440.23K. Explore Immunoprecise Antibodies Ltd (IPA) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunoprecise Antibodies Ltd Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Immunoprecise Antibodies Ltd across 1 annual periods. Also explore how large is Immunoprecise Antibodies Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Immunoprecise Antibodies Ltd (2016–2016)
Year-by-year capital reinvestment analysis for Immunoprecise Antibodies Ltd. For live market cap and broader valuation context, see Immunoprecise Antibodies Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.06x | $17.48K | $284.09K | $17.48K | — |